Recommendations for Clinical Trial Development in Follicular Lymphoma

Follicular lymphoma (FL) is the second most common lymphoid malignancy, representing 20% to 25% of all cases of non-Hodgkin’s lymphoma (NHL), and the most common of the indolent NHLs. FL is considered incurable in the majority of patients with the current standard therapeutic approaches, although ou...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Natl Cancer Inst
Main Authors: Maddocks, Kami, Barr, Paul M., Cheson, Bruce D., Little, Richard F., Baizer, Lawrence, Kahl, Brad S., Leonard, John P., Fowler, Nathan, Gordon, Leo I., Link, Brian K., Friedberg, Jonathan W., Ansell, Stephen M.
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2017
Assuntos:
Review
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6059137/
https://ncbi.nlm.nih.gov/pubmed/28040699
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djw255
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados